By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Laxatives > Miralax > MiraLAX Prescribing Information
Laxatives
https://themeditary.com/pro/miralax-prescribing-information-12728.html

MiraLAX Prescribing Information

Drug Detail:Miralax (Polyethylene glycol 3350 [ pol-ee-eth-il-een-glye-kol ])

Drug Class: Laxatives

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Drug Facts

Active ingredient (in each dose) (Bottle Only)

Polyethylene Glycol 3350, 17 g (cap filled to line)

Purpose

Osmotic Laxative

Active ingredient (in each dose) (Packet Only)

Polyethylene Glycol 3350, 17 g

Purpose

Osmotic Laxative

Indications and Usage for MiraLAX

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 1 to 3 days

Warnings

Allergy alert

Do not use if you are allergic to polyethylene glycol

Do not use if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

  • nausea, vomiting or abdominal pain
  • a sudden change in bowel habits that lasts over 2 weeks
  • irritable bowel syndrome

Ask a doctor of pharmacist before use if you are taking a prescription drug

When using this product you may have loose, watery, more frequent stools

Stop use and ask a doctor if

  • you have rectal bleeding or you nausea, bloating or cramping or abdominal pain gets worse. These may be signs of a serious condition.
  • you get diarrhea
  • you need to use a laxative for longer than 1 week

If pregnant or breast-feeding, ask a health professional before use.

Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Related/similar drugs

erythromycin, Colace, docusate, lactulose, bisacodyl, senna, polyethylene glycol 3350

MiraLAX Dosage and Administration

  • do not take more than directed unless advised by your doctor
  • the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap)
  • adults and children 17 years of age and older:
    • use once a day
    • fill to top of white section in cap which is marked to indicate the correct dose (17 g)
    • stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
    • do not combine with starch-based thickeners used for difficulty swallowing
    • ensure that the powder is fully dissolved before drinking
    • do not drink if there are any clumps
    • do not use no more than 7 days
  • children 16 years of age or under: ask a doctor

MiraLAX Dosage and Administration

  • do not take more than directed unless advised by your doctor
  • adults and children 17 years of age and older:
    • use once a day
    • stir and dissolve one packet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
    • do not combine with starch-based thickeners used for difficulty swallowing
    • ensure that the powder is fully dissolved before drinking
    • do not drink if there are any clumps
    • do not use more than 7 days
  • children 16 years of age or under: ask a doctor

Storage and Handling

  • store at 20°-25°C (68°-77°F)
  • tamper-evident: do not use if foil seal under cap, printed with "SEALED for YOUR PROTECTION" is missing, open or broken

Inactive ingredients

none

Questions or comments?

1-800-MiraLAX (1-800-647-2529)

PRINCIPAL DISPLAY PANEL - 17 g × 20 Packet Carton

20

Single Doses

#1 DOCTOR RECOMMENDED BRAND

MiraLAX ®

Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative

Mix-In Pax ®

  • Relieves Occasional Constipation/Irregularity
  • Softens Stool

20

ONCE-DAILY DOSES

Bayer

Unflavored Powder Dissolves in ANY Beverage!

UNFLAVORED
POWDER
GRIT FREE

20 PACKETS

NET WT 0.5 OZ

(17g) EACH

20ct Carton

PRINCIPAL DISPLAY PANEL - 17 g × 10 Packet Carton

10

Single Doses

#1 DOCTOR RECOMMENDED BRAND

MiraLAX ®
Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative

Mix-In Pax ®

  • Relieves Occasional Constipation/Irregularity
  • Softens Stool

10

ONCE-DAILY DOSES

Bayer

Unflavored Powder Dissolves in ANY Beverage!

UNFLAVORED
POWDER
GRIT FREE

10 PACKETS
NET WT 0.5 OZ

(17g) EACH

10ct Carton

PRINCIPAL DISPLAY PANEL - 30 Dose (510 g) Bottle Label

Easy to Pour Bottle

#1 DOCTOR RECOMMENDED BRAND

MiraLAX ®

Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative

UNFLAVORED

POWDER

GRIT FREE

  • Relieves Occasional Constipation/Irregularity
  • Softens Stool

Bayer

30 ONCE-DAILY DOSES

NET WT 17.9 OZ (510 g)

30 Front

30 Dose - Back

PRINCIPAL DISPLAY PANEL - Twinpack 2x34 Dose (578 g) Bottle Label

Twin Pack!

2 x 34 Doses

Easy to Pour Bottle

MiraLAX ®

Polyethylene Glycol 3350, Powder for Solution, Osmotic Laxative

#1 DOCTOR RECOMMENDED BRAND

  • Relieves Occasional Constipation/Irregularity
  • Softens Stool

UNFLAVORED

POWDER

GRIT FREE

Bayer

34 ONCE-DAILY DOSES

NET WT 20.4 OZ (578 g)

34 Dose Front

34 Dose Back

MIRALAX
polyethylene glycol 3350 powder, for solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11523-7268
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (POLYETHYLENE GLYCOL 3350 - UNII:G2M7P15E5P) POLYETHYLENE GLYCOL 335017 g in 17 g
Product Characteristics
Colorwhite (Colorless upon dissolution) Score
ShapeSize
FlavorImprint Code
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11523-7268-310 in 1 CARTON02/01/2007
117 g in 1 PACKET; Type 0: Not a Combination Product
2NDC:11523-7268-824 in 1 CARTON02/01/2007
217 g in 1 PACKET; Type 0: Not a Combination Product
3NDC:11523-7268-75 in 1 CARTON02/01/200701/01/2015
317 g in 1 PACKET; Type 0: Not a Combination Product
4NDC:11523-7268-4765 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product02/01/2007
5NDC:11523-7268-920 in 1 CARTON02/01/2007
517 g in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02201502/01/2007
MIRALAX
polyethylene glycol 3350 powder, for solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11523-7234
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (POLYETHYLENE GLYCOL 3350 - UNII:G2M7P15E5P) POLYETHYLENE GLYCOL 335017 g in 17 g
Product Characteristics
Colorwhite (Colorless upon dissolution) Score
ShapeSize
FlavorImprint Code
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11523-7234-117 g in 1 PACKET; Type 0: Not a Combination Product02/01/2007
2NDC:11523-7234-2119 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product02/01/2007
3NDC:11523-7234-3238 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product02/01/2007
4NDC:11523-7234-4510 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product02/01/2007
5NDC:11523-7234-512 in 1 CARTON02/01/200701/01/2012
517 g in 1 PACKET; Type 0: Not a Combination Product
6NDC:11523-7234-617 g in 1 PACKET; Type 0: Not a Combination Product02/01/2007
7NDC:11523-7234-92 in 1 CELLO PACK02/01/200701/01/2014
7510 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02201502/01/2007
MIRALAX
polyethylene glycol 3350 powder, for solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11523-7341
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (POLYETHYLENE GLYCOL 3350 - UNII:G2M7P15E5P) POLYETHYLENE GLYCOL 335017 g in 17 g
Product Characteristics
Colorwhite (Colorless upon dissolution) Score
ShapeSize
FlavorImprint Code
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11523-7341-1612 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product02/01/2007
2NDC:11523-7341-23 in 1 CARTON02/01/200709/30/2021
217 g in 1 PACKET; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02201502/01/2007
MIRALAX
polyethylene glycol 3350 powder, for solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11523-4357
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (POLYETHYLENE GLYCOL 3350 - UNII:G2M7P15E5P) POLYETHYLENE GLYCOL 335017 g in 17 g
Product Characteristics
Colorwhite (colorless upon dissolution) Score
ShapeSize
FlavorImprint Code
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11523-4357-12 in 1 PACKAGE, COMBINATION02/01/200701/01/2018
1765 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
2NDC:11523-4357-32 in 1 PACKAGE, COMBINATION02/01/2007
2578 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
3NDC:11523-4357-524 in 1 CARTON05/01/2018
317 g in 1 PACKET; Type 0: Not a Combination Product
4NDC:11523-4357-22 in 1 CARTON02/01/2007
420 in 1 CARTON
417 g in 1 PACKET; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02201502/01/2007
Labeler - Bayer HealthCare LLC. (112117283)

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by